Performance analysis of Dermata Therapeutics (DRMA)
Annual Return
Over the past 3 years, DRMA has had an average annual return of -82.41%, underperforming the benchmark SPY, which returned +22.45% annual.
Since Aug 13, 2021, DRMA has had an average annual return of -85.27%, underperforming the benchmark SPY, which returned +13.07% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -50.00% | -81.82% | -84.93% | -90.74% | -76.50% | -66.47% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0% | -50.00% | +0% | +0% | +0% | +0% | -50.00% | ||||||
| 2025 | -9.09% | -10.00% | +0% | -22.22% | -14.29% | -16.67% | +0% | +0% | -20.00% | -25.00% | +0% | -33.33% | -81.82% |
| 2024 | -19.18% | -6.78% | -10.91% | -20.41% | -20.51% | -38.71% | -26.32% | +0% | -7.14% | -23.08% | -10.00% | +22.22% | -84.93% |
| 2023 | -32.99% | -5.11% | -69.06% | +27.10% | -2.03% | +3.11% | -21.11% | -5.10% | -14.09% | -44.53% | +26.76% | -18.89% | -90.74% |
| 2022 | +29.29% | -45.33% | +1.60% | -17.57% | -24.28% | -16.63% | -10.61% | -1.96% | -8.74% | +27.05% | -2.36% | -36.60% | -76.50% |
| 2021 | +11.75% | -22.59% | +4.01% | -41.75% | -36.02% | -66.47% |
Drawdown analysis of Dermata Therapeutics (DRMA)
The maximum drawdown for the DRMA was -99.99%, occurring on Dec 26, 2025. This drawdown has not yet recovered.
The current DRMA drawdown is -99.99%.
Since Aug 13, 2021 DRMA has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 2 times
- 10% or more: 3 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.99% | Nov 3, 2021 | 1040 | Dec 26, 2025 | Ongoing | Ongoing | Ongoing |
| -28.10% | Aug 31, 2021 | 12 | Sep 17, 2021 | 33 | Nov 3, 2021 | 45 |
| -12.69% | Aug 16, 2021 | 4 | Aug 20, 2021 | 5 | Aug 27, 2021 | 9 |